PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL TO SUPPORT OPHTHALMIC SUSPENSIONS DEVELOPMENT.

被引：0
|
作者：
Le Merdy, M. [1 ]
Fan, J. [1 ]
Babiskin, A. H. [1 ]
Zhao, L. [1 ]
机构：
[1] US FDA, Silver Spring, MD USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2019年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PBPK-011
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 50 条
  • [11] A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL FOR THE ANTIBIOTIC ERTAPENEM
    Joyner, Michele L.
    Manning, Cammey C.
    Forbes, Whitney
    Maiden, Michelle
    Nikas, Ariel N.
    MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2016, 13 (01) : 119 - 133
  • [12] A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL OF ETHANOL IN THE MOUSE
    PASTINO, GM
    SULTATOS, LG
    FLYNN, EJ
    FASEB JOURNAL, 1994, 8 (05): : A952 - A952
  • [13] A physiologically-based pharmacokinetic (PBPK) model of hydroxychloroquine
    Collins, Keagan P.
    Jackson, Kristen M.
    Gustafson, Daniel L.
    CANCER RESEARCH, 2017, 77
  • [14] A Δ9-Tetrahydrocannabinol Physiologically-Based Pharmacokinetic Model Development in Humans
    Methaneethorn, Janthima
    Poomsaidorn, Chomkanang
    Naosang, Kanyamas
    Kaewworasut, Parichart
    Lohitnavy, Manupat
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2020, 45 (04) : 495 - 511
  • [15] Development of a Pediatric Physiologically-Based Pharmacokinetic Model of Clindamycin Using Opportunistic Pharmacokinetic Data
    Hornik, Christoph P.
    Wu, Huali
    Edginton, Andrea N.
    Watt, Kevin
    Cohen-Wolkowiez, Michael
    Gonzalez, Daniel
    CLINICAL PHARMACOKINETICS, 2017, 56 (11) : 1343 - 1353
  • [16] A Δ9-Tetrahydrocannabinol Physiologically-Based Pharmacokinetic Model Development in Humans
    Janthima Methaneethorn
    Chomkanang Poomsaidorn
    Kanyamas Naosang
    Parichart Kaewworasut
    Manupat Lohitnavy
    European Journal of Drug Metabolism and Pharmacokinetics, 2020, 45 : 495 - 511
  • [17] DEVELOPMENT AND VERIFICATION OF A NIFEDIPINE CONTROLLED RELEASE PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL IN
    Zaidi, S.
    Da Silva, L.
    Quinney, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S22 - S22
  • [18] DEVELOPMENT OF PHYSIOLOGICALLY-BASED PHARMACOKINETIC AND PHYSIOLOGICALLY-BASED PHARMACODYNAMIC MODELS FOR APPLICATIONS IN TOXICOLOGY AND RISK ASSESSMENT
    ANDERSEN, ME
    TOXICOLOGY LETTERS, 1995, 79 (1-3) : 35 - 44
  • [19] Development of a Pediatric Physiologically-Based Pharmacokinetic Model of Clindamycin Using Opportunistic Pharmacokinetic Data
    Christoph P. Hornik
    Huali Wu
    Andrea N. Edginton
    Kevin Watt
    Michael Cohen-Wolkowiez
    Daniel Gonzalez
    Clinical Pharmacokinetics, 2017, 56 : 1343 - 1353
  • [20] Development of a pediatric physiologically-based pharmacokinetic model to support recommended dosing of atezolizumab in children with solid tumors
    Huang, Weize
    Stader, Felix
    Chan, Phyllis
    Shemesh, Colby S.
    Chen, Yuan
    Gill, Katherine L.
    Jones, Hannah M.
    Li, Linzhong
    Rossato, Gianluca
    Wu, Benjamin
    Jin, Jin Y.
    Chanu, Pascal
    FRONTIERS IN PHARMACOLOGY, 2022, 13
12345